Antibodies, Immunity, and COVID-19
JAMA Intern Med
.
2021 Apr 1;181(4):460-462.
doi: 10.1001/jamainternmed.2020.7986.
Authors
Brad Spellberg
1
,
Travis B Nielsen
2
,
Arturo Casadevall
3
Affiliations
1
Los Angeles County + University of Southern California Medical Center, Los Angeles.
2
Department of Public Health Sciences, Parkinson School of Health Sciences and Public Health, Loyola University Chicago, Maywood, Illinois.
3
Department of Microbiology and Immunology, Johns Hopkins School of Medicine, Baltimore, Maryland.
PMID:
33231673
PMCID:
PMC8371694
DOI:
10.1001/jamainternmed.2020.7986
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Neutralizing
COVID-19*
Humans
SARS-CoV-2*
Seroepidemiologic Studies
Substances
Antibodies, Neutralizing
Grants and funding
R01 AI117211/AI/NIAID NIH HHS/United States
R21 AI132923/AI/NIAID NIH HHS/United States
R01 AI130060/AI/NIAID NIH HHS/United States
R41 AI145759/AI/NIAID NIH HHS/United States
R41 AI106375/AI/NIAID NIH HHS/United States